Moderna Says Its Vaccine for Ages Under 6 Will Be Ready for US Review in June

A vial labelled "Moderna COVID-19 Vaccine" is seen in this illustration taken on Jan. 16, 2022. Dado Ruvic/Reuters/Illustration

WASHINGTON—Moderna Inc.’s chief medical officer said on Sunday the company’s vaccine for children under 6 years old will be ready for review by a Food and Drug Administration (FDA) panel when it meets in June.

Moderna sought emergency use authorization from the FDA on Thursday.